RGT 2.90% 35.5¢ argent biopharma limited

Ann: MXC Enters Multi $M Australian Pharma Market, page-4

  1. 67 Posts.
    Deal set to generate significant medical cannabis revenues for MXC, expected to be approximately $1m in 2018 from less than 100 patients already registered.

    Thats nice
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.